期刊文献+

缬沙坦对糖尿病大鼠肾小管上皮细胞转化生长因子β1与结缔组织生长因子表达的影响 被引量:3

Effect of valsartan on the expression of transforming growth factor-β1 and connective tissue growth factor in renal tubular epithelial cells of diabetic rat
暂未订购
导出
摘要 目的:研究缬沙坦对糖尿病大鼠肾小管上皮细胞转化生长因子β1与结缔组织生长因子表达的影响。方法:将60只W istar大鼠随机分为对照组(n=20)和糖尿病模型组(n=40),糖尿病模型组给予一次腹腔注射链脲佐菌素制造糖尿病模型,模型成功后随机分为糖尿病组(n=20)和缬沙坦组(n=20);缬沙坦组每日给予缬沙坦30 m g/kg的剂量灌胃;第8周测定各组大鼠尿蛋白,处死大鼠取肾组织石蜡包埋切片,免疫组织化学法观察肾小管上皮细胞转化生长因子β1与结缔组织生长因子表达并进行半定量分析。结果:糖尿病大鼠尿蛋白排泄显著高于对照组(P<0.01),肾间质损害明显,糖尿病组大鼠肾小管上皮细胞转化生长因子β1与结缔组织生长因子阳性表达相对面积分别为0.2209±0.0405和0.1835±0.0611,与对照组比较均显著上调(P<0.01);缬沙坦组大鼠尿蛋白排泄较糖尿病组显著下降,其肾小管上皮细胞转化生长因子β1与结缔组织生长因子阳性表达相对面积分别为0.1435±0.0322和0.1183±0.0376,较糖尿病组显著下调(P<0.01)。结论:缬沙坦能显著下调糖尿病大鼠肾小管上细胞转化生长因子β1与结缔组织生长因子表达。 Objective To observe effect of valsartan on the expression on transforming growth factor-β1 and connective tissue growth factor in renal tubular epithelial ceils of diabetic rat. Methods Sixty Wistar rats were randomly divided into normal control group (n 20) and diabetic mellitus models group (n=40). Diabetic mellitus models were established by intraperitoneal injection of 60 mg/(kg · d) streptozotocin. After these models were successfully established, they were randomly divided into two groups, diabetic group who received 2.0 mL water for lavage and valsartan group who received 30 mg/(kg · d) valsartan for lavage. After eight weeks, the excretion of urinary protein was measured. The transforming growth factor-β1 and connective tissue growth factor in renal tubular epithelial ceils were detected with immunohistochemistry of SP methods. Results The excretion of urinary protein in diabetes group was significantly higher than in normal group. The positive areas of transforming growth factor-β1 and connective tissue growth factor in renal tubular epithelial ceils of diabetes group were 0. 2209±0. 0405 and 0. 1835±0. 0611, which were significantly higher(P〈0.01) than normal control group. In valsartan group, the positive areas of transforming growth factor-β1 and connective tissue growth factor in renal tubular epithelial ceils were 0. 1435±0. 0322 and 0. 1183 ±0. 0376, which were significantly lower than diabetic group (P〈0.01). Conclusion Valsartan can down-regulate the expression of transforming growth factor-β1 and connective tissue growth factor in diabetic renal tubular epithelial ceils.
出处 《实用诊断与治疗杂志》 2006年第10期722-724,共3页 Journal of Practical Diagnosis and Therapy
关键词 糖尿病 肾小管上皮细胞 转化生长因子Β1 结缔组织生长因子 缬沙坦 Diabetic mellitus renal tubular epithelial ceils transforming growth factor-β1 connective tissue growth factor valsartan
  • 相关文献

参考文献10

  • 1Ellis E N, Warady B A, Wood E G, et al. Renal structural functional relationships in early diabetes mellitus [J]. Pediatr Nephrol, 1997, 11(5): 584.
  • 2Gilbert R E, Cooper M E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury[J]? Kidney Int, 1999, 56(5): 1627.
  • 3Chen S, Hong S W, Lglesias delacFuz M C, et al. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy[J]. Ren Fail, 2001, 23 (4):471.
  • 4Nicholas S B. Advances in pathogenetic mechanisms of diabetic nephropathy[J]. Cell Mol Biol, 2003, 49(8): 1319.
  • 5Gupta S, Clarkson M R, Duggan J. Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis[J]. Kidney Int, 2000, 58(4): 1389.
  • 6Kobayashi T, Okada H, Inoue T, et al. Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy [J]. Nephrol Dial Transplant, 2006, 21(2):548.
  • 7Hanes D S, Nahar A, Weir M R. The tissue renin-angiotensinaldosterone system in diabetes mellitus[J]. Curr Hypertens Rep, 2004 , 6(2): 98.
  • 8Martinelli L, Ceriello A. Mechanism of action of ACE-inhibitors and angiotensin receptor antagonists in diabetic nephropathy. Recent insights[J]. Recenti Prog Med, 2003, 94(3): 131.
  • 9Remuzzi G, Ruggenenti P, Perna A, et al. Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoe analysis of the RENAAL trial results [J]. J Am Soc Nephrol, 2004, 15(12): 3117.
  • 10沈亚非,徐焱成.链脲佐菌素诱导实验性糖尿病大鼠模型建立的研究[J].实用诊断与治疗杂志,2005,19(2):79-80. 被引量:91

二级参考文献8

  • 1Ueda H, Ikegami H, Yamato E, et al. The NSY Mouse: a new animal model of spontaneous NIDDM with moderate obesity[J].Diabetologia , 1995,38 : 503
  • 2Rackietan N, Rackietan M L, Nadkarni M R. Studies on diabetogenic action of streptozocin (NSC-37917) [J ]. Cancer Chemother Rep, 1993,29:91
  • 3Pettepher C C, Ledoux S P, Bohr V A, et al. Repair of Alkalilabile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin[J]. J Bio Chem,1991,266:3113
  • 4Lupi R, Dotta F, Marscella L, et al. Prolonged exposure to free fatty acids has cytosatatic and pro-apototic effects on human pancreastic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway and Bcl-2redulated[J]. Diabetes, 2002,51 : 1437
  • 5Mauricio D, Mandrup-Palsen T. Apoptosis and the pathogenesis of IDDM: a question of life and death[J]. Diabetes, 1998,47:1537
  • 6Liuk, Parterson A J, Chin E, et al. Glucose stimulates protein modification by o-linked GlcNAC pancreastic beta cell: Linkage of o-linked GlcNAC to bete cell death [J]. PNAS, 2000,97(6):2820
  • 7Amos A F, Mc Carty D J, Zim Met P [J]. The rising global burden of diabetes and its complications :estimates and projections to the year 2010[J]. Diabet Med, 1997,14(Suppl 5) :SI
  • 8赵志刚.糖尿病防治若干研究进展[J].实用诊断与治疗杂志,2004,18(3):157-160. 被引量:75

共引文献90

同被引文献30

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部